These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 1920361

  • 1. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
    Samanen J, Ali F, Romoff T, Calvo R, Sorenson E, Vasko J, Storer B, Berry D, Bennett D, Strohsacker M.
    J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
    [Abstract] [Full Text] [Related]

  • 2. The in vitro pharmacological profile of SK&F 106760, a novel GPIIB/IIIA antagonist.
    Nichols AJ, Vasko JA, Valocik RE, Kopaciewicz LJ, Storer BL, Ali FE, Romoff T, Calvo R, Samanen JM.
    Thromb Res; 1994 Jul 15; 75(2):143-56. PubMed ID: 7974388
    [Abstract] [Full Text] [Related]

  • 3. Conformationally constrained peptides and semipeptides derived from RGD as potent inhibitors of the platelet fibrinogen receptor and platelet aggregation.
    Ali FE, Bennett DB, Calvo RR, Elliott JD, Hwang SM, Ku TW, Lago MA, Nichols AJ, Romoff TT, Shah DH.
    J Med Chem; 1994 Mar 18; 37(6):769-80. PubMed ID: 8145226
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D, Lider O, Dardik R, Shenkman B, Alon R, Hershkoviz R, Kapustina G, Savion N, Martinowitz U, Greenspoon N.
    Thromb Haemost; 1993 Dec 20; 70(6):1030-6. PubMed ID: 8165596
    [Abstract] [Full Text] [Related]

  • 5. Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents.
    Bovy PR, Tjoeng FS, Rico JG, Rogers TE, Lindmark RJ, Zablocki JA, Garland RB, McMackins DE, Dayringer H, Tóth MV.
    Bioorg Med Chem; 1994 Sep 20; 2(9):881-95. PubMed ID: 7712124
    [Abstract] [Full Text] [Related]

  • 6. Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.
    Imura Y, Stassen JM, Bunting S, Stockmans F, Collen D.
    Blood; 1992 Sep 01; 80(5):1247-53. PubMed ID: 1515641
    [Abstract] [Full Text] [Related]

  • 7. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure--function relationships.
    Stavrakoudis A, Bizos G, Eleftheriadis D, Kouki A, Panou-Pomonis E, Sakarellos-Daitsiotis M, Sakarellos C, Tsoukatos D, Tsikaris V.
    Biopolymers; 1992 Sep 01; 56(1):20-6. PubMed ID: 11582574
    [Abstract] [Full Text] [Related]

  • 8. Cyclic RGD peptide analogues as antiplatelet antithrombotics.
    Barker PL, Bullens S, Bunting S, Burdick DJ, Chan KS, Deisher T, Eigenbrot C, Gadek TR, Gantzos R, Lipari MT.
    J Med Chem; 1992 May 29; 35(11):2040-8. PubMed ID: 1597855
    [Abstract] [Full Text] [Related]

  • 9. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
    Hayashi Y, Katada J, Sato Y, Igarashi K, Takiguchi Y, Harada T, Muramatsu M, Yasuda E, Uno I.
    Bioorg Med Chem; 1998 Mar 29; 6(3):355-64. PubMed ID: 9568289
    [Abstract] [Full Text] [Related]

  • 10. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
    Foster MR, Hornby EJ, Brown S, Kitchin J, Hann M, Ward P.
    Thromb Res; 1993 Nov 01; 72(3):231-45. PubMed ID: 8303662
    [Abstract] [Full Text] [Related]

  • 11. Low molecular weight, non-peptide fibrinogen receptor antagonists.
    Alig L, Edenhofer A, Hadváry P, Hürzeler M, Knopp D, Müller M, Steiner B, Trzeciak A, Weller T.
    J Med Chem; 1992 Nov 13; 35(23):4393-407. PubMed ID: 1447740
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist.
    Foster MR, Hornby EJ, Brown S, Hann M, Kitchin J, Pike N, Ward P.
    Thromb Res; 1994 Aug 01; 75(3):269-84. PubMed ID: 7992238
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of the RGD peptides and the gamma chain peptide of fibrinogen on fibrinogen binding to activated platelets.
    Mohri H, Ohkubo T.
    Peptides; 1993 Aug 01; 14(2):353-7. PubMed ID: 8483813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.